Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pacemakers 16 years later].

B Dodinot

    Acta Cardiologica
    |January 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Pacemaker technology in 1976 is widely adopted, with transvenous electrode placement being standard. Advancements in lithium-iodine power sources promise longer-lasting pacemakers, simplifying patient care.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Non-valvular cardiac devices endocarditis].

    Annales de cardiologie et d'angeiologie·2008
    Same author

    [Isolated congenital complete atrio-ventricular block].

    Archives des maladies du coeur et des vaisseaux·2003
    Same author

    [Cardiac stimulation in the infant and young child].

    Archives des maladies du coeur et des vaisseaux·2003
    Same author

    [Interferences in the everyday life of the patient with a cardiac pacemaker or an implantable defibrillator].

    Archives des maladies du coeur et des vaisseaux·2003
    Same author

    [Relevance of in vitro studies for the immunity of cardiac implants in an electromagnetic field environment]].

    Archives des maladies du coeur et des vaisseaux·2003
    Same author

    [Characteristics and causes of death in 283 patients with implanted defibrillators].

    Archives des maladies du coeur et des vaisseaux·2003
    Same journal

    Dialysis-related spontaneous anterior mediastinal hemorrhage.

    Acta cardiologica·2026
    Same journal

    From the arrhythmia to the substrate: the role of atrial cardiomyopathy in atrial fibrillation management.

    Acta cardiologica·2026
    Same journal

    Presence of anti-cardiac troponin I antibodies (cTnIAb) and their role in the left ventricular remodelling, in patients with acute myocardial infarction.

    Acta cardiologica·2026
    Same journal

    Guideline-recommended medical therapy and clinical outcomes in cancer patients with de Novo heart failure.

    Acta cardiologica·2026
    Same journal

    Association between red cell distribution width and all-cause mortality in patients with congestive heart failure and atrial fibrillation.

    Acta cardiologica·2026
    Same journal

    The ventricular assist device outflow cannula anastomosis to the descending aorta in a patient with porcelain aorta.

    Acta cardiologica·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Biomedical Engineering
    • Medical Device Technology

    Context:

    • By 1976, pacemaker implantation was a well-established medical procedure.
    • Transvenous electrode placement was the predominant method, used in 95% of cases.
    • Existing nuclear and mercury pacemakers had limitations in longevity.

    Purpose:

    • To review the state of pacemaker technology and patient management in 1976.
    • To highlight advancements in pacemaker power sources and their implications.
    • To discuss the future outlook for pacemaker longevity and patient follow-up.

    Summary:

    • Pacemaker implantation techniques were highly refined by 1976, favoring transvenous electrode placement.
    • Nuclear pacemakers offered 15-year longevity, while mercury models lasted 4-5 years due to reduced current drain.

    Related Experiment Videos

  • Lithium-iodine power sources showed significant promise for future pacemakers, potentially exceeding 7 years of longevity.
  • Improved patient follow-up allowed for early detection of pacemaker malfunction, indicated by rate reduction.

    • Impact:

    • The development of longer-lasting pacemakers, particularly lithium-based ones, promised reduced replacement frequency and simpler patient management.
    • Enhanced understanding of pacemaker energy sources and failure modes improved clinical practice.
    • The trend towards miniaturization and extended longevity aimed to improve the quality of life for pacemaker recipients.